UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 861177
NEW YORK, NY
Position in DNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$646,875
+$251,018 QoQ
Shares Held
65,275
+1.1% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 183 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. DNA ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in DNA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $646,875 | 65,275 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $395,857 | 64,577 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $479,785 | 57,736 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $840,916 | 57,676 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $922,488 | 81,999 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $252,304 | 44,264 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $412,390 | 41,995 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $295,428 | 36,249 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $635,125 | 1,901,584 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,661,632 | 1,432,444 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,420,829 | 1,432,444 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,460,963 | 1,359,650 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,195,291 | 1,180,266 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,569,751 | 1,180,266 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,994,648 | 1,180,266 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,816,424 | 902,701 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,623,009 | 1,102,106 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||